The market opportunities lie in expanding GMP-compliant vaccine production facilities globally, ensuring quality raw material supply, and enhancing risk management for safety in production.

For companies in regulated industries, such as life sciences, properly managed alarm systems are key to quality assurance. Life science companies must adhere to the FDA’s Good Manufacturing Practices ...